MeiraGTx gene therapy shows positive action in early-stage study in inherited eye disorder
Seeking Alpha,
Preliminary data from a 15-subject Phase 1/2 clinical trial evaluating MeiraGTx Holdings' (NASDAQ:MGTX) gene therapy AAV-RPE65…
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, September 2008
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (91st percentile)
Mentioned by
- news
- 1 news outlet
- blogs
- 1 blog
- policy
- 1 policy source
- patent
- 73 patents
- wikipedia
- 1 Wikipedia page
- 2 Redditors
- video
- 1 YouTube creator
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 287 Mendeley
- citeulike
- 1 CiteULike